MALT-1 inhibitor (C4XD/LifeArc/University of Lausanne)

N/A

Report date: 2025/01/26 18:57:12
NME

Base Information

Drug NameMALT-1 inhibitor (C4XD/LifeArc/University of Lausanne)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetastasis Associated Lung Adenocarcinoma Transcript 1 inhibitors
TargetsMetastasis Associated Lung Adenocarcinoma Transcript 1
Therapy Area/IndicationsHematologic NeoplasmsLymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesC4X Discovery Holdings plc
China Registration ClassN/A

Develop Information

Active CompaniesLifearcUniversity Of LausanneC4X Discovery Holdings plc
Inactive CompaniesN/A
Active IndicationsHematologic NeoplasmsLymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A